newsfilter
← Latest News
Business Wire·

Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference

Rallybio Corporation (NASDAQ:RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today